Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.226
-0.016 (-6.66%)
Dec 5, 2025, 4:00 PM EST - Market closed
Theriva Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 8 | 5 | 7 | 7 | 36 | 8 | |
| Market Cap Growth | 117.38% | -33.57% | 6.57% | -80.86% | 369.38% | -10.12% | |
| Enterprise Value | 3 | -10 | -19 | -39 | -37 | 15 | |
| Last Close Price | 0.23 | 1.75 | 10.75 | 11.37 | 68.05 | 95.75 | |
| PB Ratio | 0.34 | 0.26 | 0.19 | 0.13 | 0.55 | 1.46 | |
| P/TBV Ratio | 1.13 | 0.26 | 0.23 | 0.15 | 0.55 | - | |
| Debt / Equity Ratio | 0.41 | 0.08 | 0.05 | 0.03 | 0.02 | 0.09 | |
| Quick Ratio | 0.85 | 1.97 | 3.73 | 5.95 | 18.94 | 2.26 | |
| Current Ratio | 0.90 | 2.15 | 4.07 | 6.45 | 19.38 | 2.68 | |
| Return on Equity (ROE) | -166.96% | -87.31% | -38.93% | -32.82% | -40.38% | -120.82% | |
| Return on Assets (ROA) | -29.21% | -25.85% | -21.73% | -16.95% | -22.65% | -49.52% | |
| Return on Capital (ROIC) | -57.76% | -37.47% | -28.15% | -19.57% | -24.55% | -70.79% | |
| Return on Capital Employed (ROCE) | -83.60% | -67.40% | -45.60% | -29.80% | -21.40% | -186.60% | |
| Earnings Yield | -344.23% | -526.83% | -250.32% | -286.19% | -39.70% | -131.15% | |
| FCF Yield | -243.33% | -347.85% | -261.91% | -279.10% | -35.90% | -159.02% | |
| Buyback Yield / Dilution | -572.67% | -109.24% | -5.09% | -25.76% | -541.07% | -15.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.